AU2001271683A1 - Novel secreted proteins - Google Patents

Novel secreted proteins

Info

Publication number
AU2001271683A1
AU2001271683A1 AU2001271683A AU7168301A AU2001271683A1 AU 2001271683 A1 AU2001271683 A1 AU 2001271683A1 AU 2001271683 A AU2001271683 A AU 2001271683A AU 7168301 A AU7168301 A AU 7168301A AU 2001271683 A1 AU2001271683 A1 AU 2001271683A1
Authority
AU
Australia
Prior art keywords
secreted proteins
novel secreted
novel
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271683A
Inventor
Scott R. Presnell
Paul O Sheppard
David W. Taft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001271683A1 publication Critical patent/AU2001271683A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001271683A 2000-06-30 2001-06-29 Novel secreted proteins Abandoned AU2001271683A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21544600P 2000-06-30 2000-06-30
US60/215,446 2000-06-30
PCT/US2001/020847 WO2002002626A2 (en) 2000-06-30 2001-06-29 Novel secreted proteins

Publications (1)

Publication Number Publication Date
AU2001271683A1 true AU2001271683A1 (en) 2002-01-14

Family

ID=22803010

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2001271589A Abandoned AU2001271589A1 (en) 2000-06-30 2001-06-28 Mammalian secreted proteins
AU2001271683A Abandoned AU2001271683A1 (en) 2000-06-30 2001-06-29 Novel secreted proteins
AU2001273164A Abandoned AU2001273164A1 (en) 2000-06-30 2001-07-02 Membrane associated protein zupari
AU2001271744A Abandoned AU2001271744A1 (en) 2000-06-30 2001-07-02 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001271589A Abandoned AU2001271589A1 (en) 2000-06-30 2001-06-28 Mammalian secreted proteins

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2001273164A Abandoned AU2001273164A1 (en) 2000-06-30 2001-07-02 Membrane associated protein zupari
AU2001271744A Abandoned AU2001271744A1 (en) 2000-06-30 2001-07-02 Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9

Country Status (5)

Country Link
US (6) US6822082B2 (en)
EP (1) EP1294763A2 (en)
AU (4) AU2001271589A1 (en)
CA (1) CA2415075A1 (en)
WO (4) WO2002002621A2 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030073169A1 (en) * 1997-09-18 2003-04-17 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2055400A (en) * 1998-12-18 2000-07-03 Human Genome Sciences, Inc. Prostacyclin-stimulating factor-2
US7148330B2 (en) * 1999-07-30 2006-12-12 Schering Corporation Binding compounds for IL-27
EP1878794A3 (en) * 1999-11-30 2008-01-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
US7164001B2 (en) 2000-01-20 2007-01-16 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20030096969A1 (en) * 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2409342A1 (en) * 2000-06-06 2001-12-13 Incyte Genomics, Inc. Extracellular messengers
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins
US20040044179A1 (en) * 2000-07-25 2004-03-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2001230942A1 (en) * 2000-08-28 2002-03-13 Human Genome Sciences, Inc. 7 human secreted proteins
CA2446180A1 (en) * 2001-05-10 2002-11-21 Immunex Corporation Cytokine polypeptides
GB0208925D0 (en) * 2002-04-12 2002-05-29 Univ Sheffield Polypeptide
GB0214543D0 (en) * 2002-06-24 2002-08-07 Ares Trading Sa Proteins
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
ATE388963T1 (en) * 2003-08-07 2008-03-15 Zymogenetics Inc HOMOGENEOUS PRODUCTIONS OF IL-29
WO2005046709A2 (en) * 2003-11-06 2005-05-26 Genencor International, Inc. Tgf - beta binding and supported peptides
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
WO2006083275A2 (en) * 2004-05-21 2006-08-10 The Uab Research Foundation Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
WO2006122060A1 (en) * 2005-05-06 2006-11-16 Zymogenetics, Inc. Compositions and uses of secreted polypeptide, zsig98
JP4987001B2 (en) * 2005-07-20 2012-07-25 ザイモジェネティクス リミテッド ライアビリティ カンパニー Use of truncated cysteine mutants of IL28 and IL29 to treat cancer and autoimmune disorders
CA2616122A1 (en) * 2005-07-20 2007-01-25 Zymogenetics, Inc. Il28 and il29 truncated cysteine mutants and antiviral methods of using same
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
JPWO2009001928A1 (en) * 2007-06-28 2010-08-26 アスビオファーマ株式会社 Peptide having hypotensive activity
US9421239B2 (en) 2008-10-22 2016-08-23 Trustees Of Dartmouth College Therapy and kit for the prevention and treatment of cystic fibrosis
US9333235B2 (en) 2008-10-22 2016-05-10 Trustees Of Dartmouth College Combination therapy and kit for the prevention and treatment of cystic fibrosis
US8999919B2 (en) * 2008-10-22 2015-04-07 Trustees Of Dartmouth College Compositions and methods for inhibiting the interaction between CFTR and CAL
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
PL3298033T5 (en) 2015-05-18 2023-10-30 TCR2 Therapeutics Inc. Compositions and medical uses for tcr reprogramming using fusion proteins
WO2016191263A1 (en) 2015-05-22 2016-12-01 Trustees Of Dartmouth College Therapy and kit for the prevention and treatment of cystic fibrosis
JP7109789B2 (en) 2016-08-02 2022-08-01 ティーシーアール２ セラピューティクス インク． Compositions and methods for TCR reprogramming using fusion proteins
IL292551B2 (en) 2016-10-07 2023-10-01 Tcr2 Therapeutics Inc Compositions and methods for t-cell receptors reprogramming using fusion proteins
US11851491B2 (en) 2016-11-22 2023-12-26 TCR2 Therapeutics Inc. Compositions and methods for TCR reprogramming using fusion proteins
EP3827013A4 (en) * 2018-07-26 2022-05-25 TCR2 Therapeutics Inc. Compositions and methods for tcr reprogramming using target specific fusion proteins

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412410A (en) * 1993-01-04 1995-05-02 Xerox Corporation Ink jet printhead for continuous tone and text printing
ES2204944T3 (en) * 1994-03-03 2004-05-01 Alexion Pharmaceuticals, Inc. INHIBITING FUSION GENES AND PROTEINS OF THE TERMINAL COMPLEMENT.
WO1996029405A2 (en) * 1995-03-20 1996-09-26 Ligand Pharmaceuticals Incorporated MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
AU3721397A (en) * 1996-07-09 1998-02-02 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP1914319B1 (en) * 1996-10-01 2014-11-12 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6046030A (en) * 1997-09-22 2000-04-04 Smithkline Beecham Corporation Human LIG-1 homolog (HLIG-1)
AU1455599A (en) * 1997-11-17 1999-06-07 Warner-Lambert Company P53cp, a protein that specifically binds to consensus p53 dna binding sites
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
US6330562B1 (en) * 1999-01-29 2001-12-11 International Business Machines Corporation System and method for managing security objects
JP2002538841A (en) * 1999-03-18 2002-11-19 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 27 human secretory proteins
US6842860B1 (en) * 1999-07-23 2005-01-11 Networks Associates Technology, Inc. System and method for selectively authenticating data
DE60041507D1 (en) * 1999-09-29 2009-03-19 Lexicon Pharmaceuticals Inc Human carboxypeptidases and polynucleotides encoding them
JP2003516150A (en) * 1999-12-08 2003-05-13 ジェンセット Full-length human cDNA encoding a cryptic secretory protein
GB2364477B (en) * 2000-01-18 2003-11-05 Ericsson Telefon Ab L M Virtual private networks
AU784015B2 (en) * 2000-01-19 2006-01-12 University Of Virginia Patent Foundation Sperm specific proteins
WO2001055167A1 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
WO2001055326A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002002621A2 (en) * 2000-06-30 2002-01-10 Zymogenetics, Inc. Mammalian secreted proteins
US6938155B2 (en) * 2001-05-24 2005-08-30 International Business Machines Corporation System and method for multiple virtual private network authentication schemes
US7003662B2 (en) * 2001-05-24 2006-02-21 International Business Machines Corporation System and method for dynamically determining CRL locations and access methods
US7393081B2 (en) * 2003-06-30 2008-07-01 Semiconductor Energy Laboratory Co., Ltd. Droplet jetting device and method of manufacturing pattern

Also Published As

Publication number Publication date
WO2002002636A2 (en) 2002-01-10
WO2002002621A3 (en) 2002-08-15
WO2002002604A3 (en) 2003-01-16
WO2002002626A3 (en) 2002-09-26
US20020086367A1 (en) 2002-07-04
US20020110855A1 (en) 2002-08-15
US20050214791A1 (en) 2005-09-29
WO2002002604A2 (en) 2002-01-10
AU2001273164A1 (en) 2002-01-14
US20020076779A1 (en) 2002-06-20
AU2001271589A1 (en) 2002-01-14
AU2001271744A1 (en) 2002-01-14
WO2002002621A2 (en) 2002-01-10
EP1294763A2 (en) 2003-03-26
WO2002002636A3 (en) 2002-05-02
US20020164688A1 (en) 2002-11-07
US6822082B2 (en) 2004-11-23
US20040147722A1 (en) 2004-07-29
CA2415075A1 (en) 2002-01-10
WO2002002626A2 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2001271683A1 (en) Novel secreted proteins
AU2001280471A1 (en) Novel secreted proteins and their uses
AU2002233994A1 (en) Secreted proteins
AU2002361452A1 (en) Secreted proteins
AU2001270045A1 (en) Secreted proteins
AU2002353227A1 (en) Secreted proteins
AU2001227833A1 (en) 71 human secreted proteins
AU2002232596A1 (en) Secreted human proteins
AU2002342010A1 (en) Secreted proteins
AU2001284418A1 (en) Novel polypeptide
AU2001255320A1 (en) Secreted proteins
AU2002354803A1 (en) Secreted proteins
AU2002211220A1 (en) Secreted proteins and their uses
AU2002255733A1 (en) Secreted proteins
AU2002252700A1 (en) Secreted proteins
AU2001294719A1 (en) Secreted human proteins
AU2001290551A1 (en) Secreted proteins and their uses
AU2001229366A1 (en) Secreted proteins
AU2002236440A1 (en) Novel secreted proteins and their uses
AU2002258657A1 (en) Secreted proteins
AU2002327533A1 (en) Secreted proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001229507A1 (en) 21 human secreted proteins
AU2001229503A1 (en) 17 human secreted proteins